Selective Transition Metal-Catalyzed Alkene and Alkyne Functionalization Reactions

NIH RePORTER · NIH · R35 · $341,233 · view on reporter.nih.gov ↗

Abstract

Project Summary After carbon and hydrogen; carbon, oxygen, nitrogen, and sulfur are the four of the most common elements found in pharmaceuticals and drug candidates. Lead identification and optimization is typically the longest part of the drug discovery process, taking about five out of the average fifteen years, to bring a drug to market. This is partially due to the requirement to synthesize and test of a large number of potential drug candidates through structure activity relationship (SAR) studies. As such, the development of new organic methodologies for the rapid synthesis of organic molecules is of utmost importance to synthetic chemists. The research described herein focuses on the development of novel approaches for the synthesis of C–N, C–S, C–O, and C–C bonds, in a selective and expedient manner. Moreover, it seeks to allow for divergent synthesis; where from a single common intermediate libraries of potential pharmaceuticals could be synthesized in a single synthetic transformation simply by varying the reagents. More specifically, the proposal focuses on the development of hydro- and oxidative functionalization of carbon-carbon double bonds using transition metal catalysts.

Key facts

NIH application ID
9999621
Project number
5R35GM125029-04
Recipient
UNIVERSITY OF TEXAS AT AUSTIN
Principal Investigator
Kami Lee Hull
Activity code
R35
Funding institute
NIH
Fiscal year
2020
Award amount
$341,233
Award type
5
Project period
2017-08-01 → 2022-07-31